The U.S. Air Force Life Cycle Management Center has issued a request for white papers for the Counter-Air Missile Program, or CAMP.
What Is CAMP Aiming to Develop?
According to a presolicitation notice published Friday on SAM.gov, the effort aligns with the Air Force Armament Directorate’s M-Series Modular Weapon approach and aims to develop a low-cost, high-volume, open, modular counter‑air missile system. The initial system will demonstrate ground-launch capability, with future iterations potentially adapted for air-to-air applications. It is also intended to become part of the Affordable Mass Munitions portfolio.
Phase 1 will focus on developing, integrating and testing system prototypes using incremental capability cycles, culminating in a ground-launched prototype and a complete Product-Level Technical Data Package ready for high-rate production. Phase 1 is expected to last 24 months. Phase 2 would transition the ground-launched CAMP system into official research, development, test and evaluation, or RDT&E, and production.
The program aims to utilize high technology readiness level, or TRL, components to minimize new development needs and achieve a first flight test within nine months. It targets an annual production rate of 1,000 to 3,500 units, while keeping the CAMP system all-up round, or AUR, cost below $500,000 for a minimum production of 1,000 units.
Responses to the presolicitation will be accepted until Dec. 2.
Related Articles
The Small Business Administration has cleared the backlog of Veteran Small Business Certification, or VetCert, applications, allowing veteran entrepreneurs to compete for federal contracts without delay. SBA said Tuesday pending applications dropped from more than 2,700 to zero, and average processing times are now just 12 days. SBA Administrator Kelly Loeffler said veterans deserve full support when starting and growing businesses. “With the 2,700 case backlog cleared, veteran job creators finally have the chance to compete for contracts in the federal marketplace – and to access the opportunities they deserve,” Loeffler added. Under Loeffler’s leadership, SBA restored full staffing and
The Food and Drug Administration has appointed Richard Pazdur, the founding director of the agency’s Oncology Center of Excellence, as the new head of the Center for Drug Evaluation and Research. A 26-year veteran of the FDA, Pazdur has held multiple leadership roles in oncology and drug evaluation. He retains oversight of the Oncology Center of Excellence pending the appointment of a successor. Federal healthcare agencies continue to explore ways to improve operations and service delivery through technology and collaboration. The Potomac Officers Club’s 2025 Healthcare Summit—rescheduled to Feb. 12—will feature leaders from CMS, NIH, DHA and other organizations discussing
The Department of Energy has approved Oklo’s nuclear safety design agreement, or NSDA, for its Aurora Fuel Fabrication Facility, or A3F, at Idaho National Laboratory. Oklo said Tuesday the facility, which was selected to participate in DOE’s Advanced Nuclear Fuel Line Pilot Projects, received approval in just under two weeks, marking the first NSDA under the program. Why Is the NSDA Approval Significant for Oklo’s A3F? According to Oklo, the approval from DOE’s Idaho Operations Office demonstrates a new authorization pathway that could expand U.S. industrial capacity, strengthen national energy security and accelerate production scale-up for advanced nuclear fuel. “This